Please provide your email address to receive an email when new articles are posted on . Sequelae such as hyperpigmentation is common among laser-treated patients, especially those with skin of color.

LOS ANGELES, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, and HALO ...

For men with low-risk prostate cancer, focal laser ablation treats just the diseased portion of the prostate rather than the entire gland. A phase 1 trial found it was safe. None of the nine men in ...

Focal therapy is emerging as an alternative to active surveillance for the management of low-risk prostate cancer in carefully selected patients. The aim of focal therapy is long-term cancer control ...

LOS ANGELES, March 28, 2024 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems Americas, Inc. (CLS), a leading provider of office-based, focal laser ablation (FLA) systems for urologists, today ...

Up until now, capturing an image of a prostate cancer has been difficult because prostate tissue and tumor tissue are so similar. Precise, non-invasive surgical treatment has proved difficult as a ...

Chemoprevention and epigenetic multitargeted approach. This is an ASCO Meeting Abstract from the 2016 Cancer Survivorship Symposium. This abstract does not include a full text component.

Focal laser ablation (FLA) for prostate cancer shows "promising early oncologic results" and "acceptable morbidity" in men with low- to intermediate-risk prostate cancer, concludes a new single-center ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...